Eli

Long ACAD above $30. Target 31 and 35 in January.

Eli 已更新   
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
4
ACAD in a money squeeze that appears to release soon to the upside coinciding with resistance break through. Daily MACD turned bullish and major MAs turning up. A good long idea upon confirmation of break out.
交易進行:
Breakout occurred and Price is back to the $30 breakout level, testing it as support. If support holds, go long still targeting $35. If support fails, 24 and 20 are downside targets.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。